X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare AANJANEYA LIFECARE with WYETH LTD - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DR. DATSONS LABS vs WYETH LTD - Comparison Results

WYETH LTD 
   Change

Wyeth Limited is the 51% subsidiary of Wyeth, US and is the sixth largest company among multinationals with revenues of Rs 2.9 bn in FY07. The company derives its revenues from pharmaceutical and OTC segments with focus on various therapeutic areas s... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DR. DATSONS LABS WYETH LTD DR. DATSONS LABS/
WYETH LTD
 
P/E (TTM) x -10.9 27.7 - View Chart
P/BV x 0.2 5.3 3.0% View Chart
Dividend Yield % 0.0 1.3 -  

Financials

 DR. DATSONS LABS   WYETH LTD
EQUITY SHARE DATA
    DR. DATSONS LABS
Mar-14
WYETH LTD
Mar-13
DR. DATSONS LABS/
WYETH LTD
5-Yr Chart
Click to enlarge
High Rs1261,044 12.0%   
Low Rs31818 3.8%   
Sales per share (Unadj.) Rs133.0298.6 44.5%  
Earnings per share (Unadj.) Rs0.257.2 0.3%  
Cash flow per share (Unadj.) Rs6.658.4 11.3%  
Dividends per share (Unadj.) Rs017.00 0.0%  
Dividend yield (eoy) %01.8 0.0%  
Book value per share (Unadj.) Rs128.8249.5 51.6%  
Shares outstanding (eoy) m31.6622.72 139.3%   
Bonus/Rights/Conversions FCCB--  
Price / Sales ratio x0.63.1 18.9%   
Avg P/E ratio x516.116.3 3,172.6%  
P/CF ratio (eoy) x11.815.9 74.3%  
Price / Book Value ratio x0.63.7 16.3%  
Dividend payout %029.7 0.0%   
Avg Mkt Cap Rs m2,47721,157 11.7%   
No. of employees `000NA0.5 0.0%   
Total wages/salary Rs m56400 14.0%   
Avg. sales/employee Rs ThNM13,787.4-  
Avg. wages/employee Rs ThNM813.0-  
Avg. net profit/employee Rs ThNM2,643.3-  
INCOME DATA
Net Sales Rs m4,2116,783 62.1%  
Other income Rs m79353 22.3%   
Total revenues Rs m4,2897,136 60.1%   
Gross profit Rs m5691,617 35.2%  
Depreciation Rs m20427 768.4%   
Interest Rs m4306 7,821.8%   
Profit before tax Rs m131,938 0.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m-20-   
Extraordinary Inc (Exp) Rs m0-5 0.0%   
Tax Rs m6632 1.0%   
Profit after tax Rs m51,301 0.4%  
Gross profit margin %13.523.8 56.6%  
Effective tax rate %48.032.6 147.2%   
Net profit margin %0.119.2 0.6%  
BALANCE SHEET DATA
Current assets Rs m6,8526,984 98.1%   
Current liabilities Rs m6,7112,056 326.4%   
Net working cap to sales %3.372.6 4.6%  
Current ratio x1.03.4 30.1%  
Inventory Days Days16199 162.0%  
Debtors Days Days31824 1,330.4%  
Net fixed assets Rs m3,673244 1,503.5%   
Share capital Rs m317227 139.3%   
"Free" reserves Rs m3,7615,441 69.1%   
Net worth Rs m4,0785,668 71.9%   
Long term debt Rs m1,67125 6,683.2%   
Total assets Rs m12,6337,901 159.9%  
Interest coverage x1.0353.3 0.3%   
Debt to equity ratio x0.40 9,290.1%  
Sales to assets ratio x0.30.9 38.8%   
Return on assets %3.416.5 20.8%  
Return on equity %0.122.9 0.5%  
Return on capital %7.734.0 22.5%  
Exports to sales %22.90.2 10,493.7%   
Imports to sales %14.336.3 39.3%   
Exports (fob) Rs m96415 6,513.5%   
Imports (cif) Rs m6022,465 24.4%   
Fx inflow Rs m96415 6,342.1%   
Fx outflow Rs m6072,677 22.7%   
Net fx Rs m357-2,662 -13.4%   
CASH FLOW
From Operations Rs m1,345923 145.7%  
From Investments Rs m-2,256317 -711.8%  
From Financial Activity Rs m-1,200-481 249.4%  
Net Cashflow Rs m-2,111759 -278.1%  

Share Holding

Indian Promoters % 4.5 0.0 -  
Foreign collaborators % 0.0 51.1 -  
Indian inst/Mut Fund % 0.0 11.3 -  
FIIs % 1.4 7.2 18.8%  
ADR/GDR % 0.0 0.0 -  
Free float % 94.1 30.4 309.5%  
Shareholders   20,807 21,978 94.7%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DR. DATSONS LABS With:   ELDER PHARMA  FDC LTD.  SUN PHARMA  STRIDES SHASUN LTD  TTK HEALTHCARE  

Compare DR. DATSONS LABS With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Finishes on a Flat Note; Idea Plunges 5% on Weak Q3 Peformance(Closing)

Indian share markets finished on a flat note after a five-session record-setting spree as profit booking was witnessed in metal stocks, capital goods stocks.

Related Views on News

Apollo Micro Systems Ltd. (IPO)

Jan 9, 2018

Should you subscribe to the IPO of Apollo Micro Systems Ltd?

Khadim India Ltd. (IPO)

Oct 31, 2017

Should you subscribe to the IPO of Khadim India Ltd?

Mahindra Logistics Ltd. (IPO)

Oct 28, 2017

Should you subscribe to the IPO of Mahindra Logistics Ltd?

Godrej Agrovet Ltd. (IPO)

Oct 4, 2017

Should you subscribe to the IPO of Godrej Agrovet Limited?

Matrimony.com (IPO)

Sep 11, 2017

Should you subscribe to the IPO of Matrimony.com?

More Views on News

Most Popular

Mutual Funds Clearly Tell Us That There is a Bubble in the Stock Market(Vivek Kaul's Diary)

Jan 11, 2018

The maximum amount of money ever has come into equity mutual funds during the current financial year.

Did GST and Notebandi Help? Sherlock Holmes Finds Out...(The 5 Minute Wrapup)

Jan 13, 2018

Discussions with my cousin helped me understand the situation on Ground Zero - after the demonetization and GST upheaval. Here's what that means for listed companies...

Nirvana denied: Has Value Failed?(The Honest Truth)

Jan 13, 2018

Should investors choose growth over value this year?

'Smart Money' Enters Bitcoin. Will You?(Smart Contrarian)

Jan 17, 2018

As institutional money enters bitcoin, the gains over the last year could just be the tip of the iceberg.

Increasing Divergence Between Bond Yields and Earnings Yield(Chart Of The Day)

Jan 11, 2018

Over the past couple of months, bond yields have risen, but earning yields have fallen, increasing divergence.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

DR. DATSONS LABS SHARE PRICE


May 21, 2015 (Close)

TRACK DR. DATSONS LABS

  • Track your investment in DR. DATSONS LABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DR. DATSONS LABS

DR. DATSONS LABS - AJANTA PHARMA COMPARISON

COMPARE DR. DATSONS LABS WITH

MARKET STATS